Clinical Trial Update: Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell Anemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing sulfadoxine-pyrimethamine to weekly chloroquine for malaria prevention in children with sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Sickle Cell Disease

Drugs mentioned

• Chloroquine (chloroquine)
• Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: Makerere University | Conditions: Sickle Cell Anemia, Malaria | Phase 3 | Status: COMPLETED